A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary sclerosing cholangitis, and a pharmaceutical useful as a therapeutic agent and a preventive agent for obesity, fatty liver and steatohepatitis are provided. A benzothiazepine or benzothiepine compound represented by the following formula (1A) having a thioamide bond and a quaternary ammonium substitutent:
A method for inhibiting ileal bile acid transporter activity in a subject, comprising administering to said subject an effective amount of a compound represented by formula (1):
一种抑制回肠胆汁酸转运蛋白活性的方法,包括向该受试者施用一种由式(1)所代表的化合物的有效量:
NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS
申请人:Asahi Kasei Pharma Corporation
公开号:EP1719768B1
公开(公告)日:2012-04-25
ASINGER F.; KAUSSEN M.; GOLD-MARTIN I.; SAUS A., MONATSH. CHEM., 1981, 112, NO 5, 643-657
作者:ASINGER F.、 KAUSSEN M.、 GOLD-MARTIN I.、 SAUS A.